MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

22 Oct 2021 Evaluate
The Sales for the quarter ended September 2021 of Rs. 200.30 million declined by -97.37% from Rs. 7607.50 millions.An average growth of 40.64% was recorded for the quarter ended September 2021 to Rs. 880.80  millions from Rs. 626.30 millions.Operating profit for the quarter ended September 2021 decreased to 1032.30 millions as compared to 1320.30 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 200.30 7607.50 -97.37 402.90 15147.00 -97.34 27095.00 31399.00 -13.71
Other Income 1060.80 128.90 722.96 1101.90 218.70 403.84 478.80 1732.30 -72.36
PBIDT 1032.30 1320.30 -21.81 1103.50 2723.60 -59.48 4749.40 5441.40 -12.72
Interest 75.70 272.10 -72.18 146.80 669.30 -78.07 1018.00 1362.00 -25.26
PBDT 956.60 1048.20 -8.74 956.70 2054.30 -53.43 3731.40 4062.40 -8.15
Depreciation 15.40 295.90 -94.80 30.60 591.20 -94.82 999.70 1074.00 -6.92
PBT 941.20 752.30 25.11 926.10 1463.10 -36.70 2731.70 2988.40 -8.59
TAX 60.40 126.00 -52.06 56.60 316.40 -82.11 586.90 -223.00 -363.18
Deferred Tax -101.00 -4.80 2004.17 -101.00 -4.80 2004.17 0.00 0.00 0.00
PAT 880.80 626.30 40.64 869.50 1146.70 -24.17 2144.80 3211.40 -33.21
Equity 159.30 159.30 0.00 159.30 159.30 0.00 159.30 159.30 0.00
PBIDTM(%) 515.38 17.36 2869.58 273.89 17.98 1423.21 17.53 17.33 1.15
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..